Integrated Proteins Limited (BOM:519606)
13.72
+0.65 (4.97%)
At close: Nov 13, 2026
Integrated Proteins Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.05 | -0.16 | 0.87 | 0.62 | 0.27 | 0.36 |
Cash & Short-Term Investments | 1.05 | -0.16 | 0.87 | 0.62 | 0.27 | 0.36 |
Cash Growth | 19.95% | - | 41.95% | 128.63% | -24.22% | -49.72% |
Accounts Receivable | 5.69 | 20.63 | - | - | - | - |
Other Receivables | - | - | - | - | 0.03 | 0.02 |
Receivables | 5.69 | 20.63 | - | - | 0.03 | 0.02 |
Other Current Assets | 243.19 | 185.17 | 322.31 | 0.38 | 0.38 | 0.3 |
Total Current Assets | 249.93 | 205.64 | 323.19 | 0.99 | 0.68 | 0.67 |
Property, Plant & Equipment | 0.46 | 0.46 | 0.46 | 4.15 | 4.08 | 4.36 |
Long-Term Investments | 0 | 0 | 0 | 1.53 | 1.02 | 1.04 |
Long-Term Accounts Receivable | - | - | - | - | 0.23 | 0.23 |
Other Long-Term Assets | - | - | 0.07 | 3.31 | 3.78 | 3.77 |
Total Assets | 250.4 | 206.11 | 323.72 | 27.38 | 28.13 | 26.87 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.06 | - | 80.03 | 0.13 | 0.57 | 0.52 |
Accrued Expenses | - | 0.38 | 0.38 | 0.44 | 0.24 | 0.4 |
Short-Term Debt | 38.81 | - | 38.96 | - | - | - |
Current Income Taxes Payable | - | 0.42 | 0.8 | 0.24 | - | - |
Other Current Liabilities | 2.05 | 0.05 | 2.37 | 0.01 | 0.01 | 0.01 |
Total Current Liabilities | 40.92 | 0.84 | 122.54 | 0.83 | 0.81 | 0.93 |
Long-Term Debt | - | - | - | 0.35 | 1.91 | 0.8 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.11 | 0.21 | 0.3 |
Other Long-Term Liabilities | 0 | - | -0 | 0 | - | -0.05 |
Total Liabilities | 40.92 | 0.84 | 122.54 | 1.29 | 2.93 | 1.98 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 187.14 | 190.3 | 35.2 | 35.2 | 35.2 | 35.2 |
Retained Earnings | 22.35 | 14.97 | 165.98 | -9.11 | -10 | -10.31 |
Shareholders' Equity | 209.48 | 205.27 | 201.18 | 26.09 | 25.2 | 24.89 |
Total Liabilities & Equity | 250.4 | 206.11 | 323.72 | 27.38 | 28.13 | 26.87 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 38.81 | - | 38.96 | 0.35 | 1.91 | 0.8 |
Net Cash (Debt) | -37.76 | -0.16 | -38.08 | 0.27 | -1.64 | -0.44 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.21 | -0.00 | -1.08 | 0.01 | -0.05 | -0.01 |
Filing Date Shares Outstanding | 19.67 | 187.14 | 32.04 | 32.04 | 32.04 | 32.04 |
Total Common Shares Outstanding | 19.67 | 187.14 | 32.04 | 32.04 | 32.04 | 32.04 |
Working Capital | 209.02 | 204.8 | 200.64 | 0.16 | -0.13 | -0.26 |
Book Value Per Share | 10.65 | 1.10 | 6.28 | 0.81 | 0.79 | 0.78 |
Tangible Book Value | 209.48 | 205.27 | 201.18 | 26.09 | 25.2 | 24.89 |
Tangible Book Value Per Share | 10.65 | 1.10 | 6.28 | 0.81 | 0.79 | 0.78 |
Land | - | - | - | - | 2.62 | 2.62 |
Buildings | - | - | - | - | 6.18 | 6.18 |
Machinery | - | - | - | - | 1.81 | 1.81 |